Designed to expand to every demand, the GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes 1-3 through flexibility, strength and accuracy to treat aortoiliac occlusive disease.

The GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of de novo or restenotic lesions found in iliac arteries with reference vessel diameters ranging from 5 mm–13 mm and lesion lengths up to 110 mm, including lesions at the aortic bifurcation.

The GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of de novo or restenotic lesions found in iliac arteries with reference vessel diameters ranging from 5 mm - 13 mm and lesion lengths up to 110 mm, including lesions at the aortic bifurcation.

Designed to perform in challenging situations, the GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes † through flexibility, strength and accuracy to treat a wide range of clinical conditions.

View catalogue numbers and specifications, like introducer sheath size and guidewire diameter, for the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis.

As an MR Conditional device, the VIABAHN® VBX offers safety in specific MRI environments. Consult the IFU for detailed conditions and updates.

Case Study: A modern approach to iliac artery stenting utilizing the lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

Designed to expand to every demand, the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes through flexibility, strength and accuracy to treat aortoiliac occlusive disease.

† The GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis indication includes de novo or restenotic lesions in iliac arteries, including those at the aortic bifurcation.

The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease.